Team
Alex Wieseler
Chief Operating Officer
PATH EX, Inc.
PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood, regardless of type, for the treatment of sepsis.
PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood, regardless of type, for the treatment of sepsis.
Chief Operating Officer
Investable Memphis is powered by
Investable Memphis showcases companies based in the Bluff City that are actively growing and raising capital. Memphis is primed for investment from angels and VC funds both in and outside the region. Search our rising companies to find the next piece of your portfolio, and join our investor community by subscribing to our newsletter for investment opportunities and exclusive events.
Get updates on investor opportunities and events.